Gail Carson
Impact in
- Infectious Diseases top 1%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Viral gastroenteritis research and epidemiology
- Neurology top 5%
- Long-Term Effects of COVID-19
Papers in
-
- SARS-CoV-2 and COVID-19 Research 5
- COVID-19 Clinical Research Studies 4
- Viral gastroenteritis research and epidemiology 1
-
- Long-Term Effects of COVID-19 2
- Vagus Nerve Stimulation Research 1
Gail Carson
18 papers receiving 2.3k citations
Gail Carson's Hit Papers
Peers
Comparison fields: 5 of 117
- Infectious Diseases 1.4k
- Neurology 241
- Modeling and Simulation 74
- Immunology 284
- Animal Science and Zoology 140
Countries citing papers authored by Gail Carson
This map shows the geographic impact of Gail Carson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gail Carson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gail Carson more than expected).
Fields of papers citing papers by Gail Carson
This network shows the impact of papers produced by Gail Carson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gail Carson. The network helps show where Gail Carson may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses Hit paper breakdown → | 2022 | 740 |
| 2 | Mapping the human genetic architecture of COVID-19 Hit paper breakdown → | 2021 | 641 |
| 3 | 2021 | 160 | |
| 4 | 2021 | 135 | |
| 5 | GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 Hit paper breakdown → | 2023 | 121 |
| 6 | Genomic investigations of unexplained acute hepatitis in children Hit paper breakdown → | 2023 | 92 |
| 7 | 2022 | 86 | |
| 8 | 2021 | 75 | |
| 9 | 2021 | 68 | |
| 10 | 2021 | 66 | |
| 11 | 2021 | 50 | |
| 12 | 2023 | 32 | |
| 13 | 2023 | 23 | |
| 14 | 2023 | 22 | |
| 15 | 2021 | 21 | |
| 16 | 2022 | 16 | |
| 17 | 2022 | 10 | |
| 18 | 2023 | 5 |
About Gail Carson
Gail Carson is a scholar working on Infectious Diseases, Neurology, Epidemiology, Applied Microbiology and Biotechnology and Immunology, having authored 18 papers that have together received 2.4k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 Clinical Research Studies (4 papers), Long-Term Effects of COVID-19 (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Viral gastroenteritis research and epidemiology (1 paper), Animal Virus Infections Studies (1 paper), interferon and immune responses (1 paper) and Vagus Nerve Stimulation Research (1 paper). The work is most often cited by research in Infectious Diseases (1.4k citations), Neurology (241 citations), Modeling and Simulation (74 citations), Immunology (284 citations) and Animal Science and Zoology (140 citations). Gail Carson has collaborated with scholars based in United Kingdom, United States and Austria. Their work appears in journals such as Nature, The Lancet Respiratory Medicine, EBioMedicine, Scientific Reports and Archives of Pediatrics and Adolescent Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.